VIR
Vir Biotechnology Inc
11.80$
+5.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -30.0% | +0.8% | -5.7% | -32.0% | -0.3% | -0.7% | +232.3% | -68.5% | -3.3% | -3.0% | +99.7% | – | |
| – | +4.9% | -16.0% | -6.7% | -24.7% | -5.1% | -11.2% | -11.4% | -8.8% | +98.7% | -46.4% | +102.5% | – | |
| – | – | – | – | – | -197.2% | – | -196.2% | – | – | – | – | – | |
| – | -58.7% | +22.0% | -64.4% | +253.8% | +2.2% | -32.3% | +55.8% | -87.5% | +1,314.5% | -91.3% | +8.2% | – | |
| – | +77.8% | – | +644.6% | -44.0% | +18.7% | -9.9% | -55.5% | -28.4% | +114.2% | -86.3% | -1,665.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +506.5% | -91.0% | +1,835.5% | -98.9% | +3,974.2% | -52.7% | +242.1% | -95.0% | +918.6% | +15,542.3% | +48.2% | – | |
| – | – | – | – | -138.7% | – | -9.3% | -225.2% | – | – | -32.1% | +10.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.